Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells

Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome

(2015) Seunghoon Han et al.   Journal of Hematology & Oncology

Role of DNA methylation in renal cell carcinoma

(2015) Niraj Shenoy et al.   Journal of Hematology & Oncology

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

(2014) Bertrand Coiffier et al.   Journal of Hematology & Oncology

CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia

(2014) Hana Hájková et al.   Journal of Hematology & Oncology

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

(2010) Jiahuai Tan et al.   Journal of Hematology & Oncology

Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells

(2007) Hongzhen Li et al.   EXPERIMENTAL CELL RESEARCH